Sign inJoin waitlistJoin the waitlist

Jennifer Diamond

Medical Director of Cancer Clinical Trials Office · University of Colorado School of Medicine

Credentials: · · · ·

History

Cancer Clinical Trials Office · University of Colorado School of Medicine
Present
University of Colorado School of Medicine
Present

Medical Oncology
2007–2009
Internal Medicine
2004–2007
Doctor of Medicine
2000–2004

Research

Sacituzumab Govitecan-hziy in Refractory Metastatic Triple-Negative Breast Cancer
New England Journal of Medicine · 2019 · 702 citations
Efficacy and Safety of Anti-Trop-2 Antibody Drug Conjugate Sacituzumab Govitecan (IMMU-132) in Heavily Pretreated Patients With Metastatic Triple-Negative Breast Cancer
Journal of Clinical Oncology · 2017 · 347 citations
Atezolizumab Plus nab-Paclitaxel in the Treatment of Metastatic Triple-Negative Breast Cancer With 2-Year Survival Follow-up: A Phase 1b Clinical Trial
JAMA Oncology · 2019 · 233 citations

Gail Eckhardt
29 papers
Peter Kabos
19 papers · 1 as a fellow
Virginia Borges
16 papers
Wells Messersmith
16 papers
Antonio Jimeno
11 papers
Sarah Davis
11 papers
AC
Anna Capasso
10 papers
Anna Schreiber
10 papers · 9 as a fellow
Christopher Lieu
10 papers
Anthony Elias
9 papers
Bradley Corr
8 papers
Elena Shagisultanova
8 papers

Grants

The Development of Novel Individualized Therapy for Triple-Negative Breast Cancer
National Cancer Institute · K23
Contact PI · $858.6K · University of Colorado Denver
2013–2018
The Development of Novel Individualized Therapy for Metastatic Triple Negative B
National Cancer Institute · R21
Contact PI · $373.2K · University of Colorado Denver
2012–2015

Clinical trials

Radiotherapy in Combo With Chemo and Immunotherapy in Patients With PD-L1 Positive Metastatic TNBC
Principal investigator · Withdrawn · Phase 2
University of Colorado, Denver
2022
A Study of OKI-179 in Patients With Solid Tumors
Principal investigator · Completed · Phase 1
OnKure, Inc.
2019–2021
Phase I Study of MLN0128 and MLN8237 in Patients With Advanced Solid Tumors and Metastatic Triple-negative Breast Cancer
Principal investigator · Completed · Phase 1
University of Colorado, Denver
2016–2020
Testing the Addition of an Individualized Vaccine to Durvalumab and Tremelimumab and Chemotherapy in Patients With Metastatic Triple Negative Breast Cancer
Site PI · Recruiting · Phase 2
National Cancer Institute (NCI)
2021–2026